Serial Number | 77377366 |
Word Mark | THERABANK |
Filing Date | Tuesday, January 22, 2008 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, January 4, 2010 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Consulting and advisory services relating to diagnostic preparations and products, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, development, testing and efficacy of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments namely, development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, provision of assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues; Design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; Scientific research related to pharmacogenetics; Research and advisory services relating to pharmaceuticals |
Goods and Services | Medical diagnostic services; Medical diagnostic testing relating to the human body, namely, analysis of samples to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Medical diagnostic testing relating to the human body, namely, analysis of samples to confirm diagnosis of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Medical clinical services, namely, analysis of samples of DNA, RNA and bodily tissues to prescribe the prescribe the most efficient and/or efficacious pharmaceutical product to the patient; Medical clinical services, namely, the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals or other medical treatment; Medical and scientific research in the nature of conducting clinical trials; Compilation of medical reports relating to prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Compilation of medical reports relating to confirmation of diagnosis of diseases and disorders of the body, and prescription of most efficient and efficacious pharmaceutical product or method for treatment thereof; Compilation of medical reports as a resource of phenotypic and genotypic data relating to diseases and disorders of the central nervous system and psychiatric diseases and disorders; Conducting medical examinations for diagnosis and treatments of disease; Testing and profiling of pharmaceutical preparations and treatments for medical purposes; Computer aided diagnostic testing services relating to the human body |
Pseudo Mark | THERA BANK |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 25, 2008 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 25, 2008 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | TheraGenetics Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Denmark Hill, London SE58AF GB |
Event Date | Event Description |
Monday, January 4, 2010 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Monday, January 4, 2010 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, June 1, 2009 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Monday, June 1, 2009 | INQUIRY TO SUSPENSION E-MAILED |
Monday, June 1, 2009 | SUSPENSION INQUIRY WRITTEN |
Monday, June 1, 2009 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
Thursday, May 28, 2009 | ASSIGNED TO LIE |
Friday, November 28, 2008 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, November 28, 2008 | LETTER OF SUSPENSION E-MAILED |
Friday, November 28, 2008 | SUSPENSION LETTER WRITTEN |
Tuesday, November 18, 2008 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, November 18, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, November 18, 2008 | ASSIGNED TO LIE |
Wednesday, November 5, 2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, May 5, 2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, May 5, 2008 | NON-FINAL ACTION E-MAILED |
Monday, May 5, 2008 | NON-FINAL ACTION WRITTEN |
Tuesday, April 29, 2008 | ASSIGNED TO EXAMINER |
Saturday, January 26, 2008 | NOTICE OF PSEUDO MARK MAILED |
Friday, January 25, 2008 | NEW APPLICATION ENTERED IN TRAM |